Werba JP[Author] - Search Results

Year	Number of Results
1992	1
1993	3
1994	2
1995	1
1996	3
2001	1
2003	2
2004	1
2005	1
2006	3
2007	2
2008	3
2009	3
2010	1
2011	1
2012	3
2013	6
2014	3
2015	3
2016	1
2017	3
2018	3
2019	2
2020	7
2021	4
2022	2

1

Overview of green tea interaction with cardiovascular drugs.

Werba JP, Misaka S, Giroli MG, Yamada S, Cavalca V, Kawabe K, Squellerio I, Laguzzi F, Onoue S, Veglia F, Myasoedova V, Takeuchi K, Adachi E, Inui N, Tremoli E, Watanabe H. Werba JP, et al. Curr Pharm Des. 2015;21(9):1213-9. doi: 10.2174/1381612820666141013135045. Curr Pharm Des. 2015. PMID: 25312732 Review.

2

Update of green tea interactions with cardiovascular drugs and putative mechanisms.

Werba JP, Misaka S, Giroli MG, Shimomura K, Amato M, Simonelli N, Vigo L, Tremoli E. Werba JP, et al. J Food Drug Anal. 2018 Apr;26(2S):S72-S77. doi: 10.1016/j.jfda.2018.01.008. Epub 2018 Feb 14. J Food Drug Anal. 2018. PMID: 29703388 Free article. Review.

3

Traditional Risk Factors are Causally Related to Carotid Intima-Media Thickness Progression: Inferences from Observational Cohort Studies and Interventional Trials.

Frigerio B, Werba JP, Amato M, Ravani A, Sansaro D, Coggi D, Vigo L, Tremoli E, Baldassarre D. Frigerio B, et al. Among authors: werba jp. Curr Pharm Des. 2020;26(1):11-24. doi: 10.2174/1381612825666191213120339. Curr Pharm Des. 2020. PMID: 31838990 Free article. Review.

4

Statins in atherothrombosis.

Colli S, Werba JP, Tremoli E. Colli S, et al. Among authors: werba jp. Semin Vasc Med. 2004 Nov;4(4):407-15. doi: 10.1055/s-2004-869598. Semin Vasc Med. 2004. PMID: 15861322 Review.

5

Trials in "True" Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk.

Werba JP, Vigo LM, Veglia F, Marenzi G, Tremoli E, Baldassarre D. Werba JP, et al. Clin Pharmacol Ther. 2019 Nov;106(5):960-967. doi: 10.1002/cpt.1436. Epub 2019 Apr 29. Clin Pharmacol Ther. 2019. PMID: 30916778 Free PMC article. Review.

6

Assessment and relevance of carotid intima-media thickness (C-IMT) in primary and secondary cardiovascular prevention.

Ravani A, Werba JP, Frigerio B, Sansaro D, Amato M, Tremoli E, Baldassarre D. Ravani A, et al. Among authors: werba jp. Curr Pharm Des. 2015;21(9):1164-71. doi: 10.2174/1381612820666141013121545. Curr Pharm Des. 2015. PMID: 25312737 Free PMC article. Review.

7

Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis.

Baldassarre D, De Jong A, Amato M, Werba JP, Castelnuovo S, Frigerio B, Veglia F, Tremoli E, Sirtori CR. Baldassarre D, et al. Among authors: werba jp. Ann Med. 2008;40(1):21-44. doi: 10.1080/07853890701645399. Ann Med. 2008. PMID: 17934910 Review.

8

Persistent long-term platelet activation and endothelial perturbation in women with Takotsubo syndrome.

Amadio P, Porro B, Cavalca V, Barbieri SS, Eligini S, Fiorelli S, Di Minno A, Gorini A, Giuliani M, Werba JP, Cosentino N, Olivares P, Barbieri S, Veglia F, Tremoli E, Trabattoni D. Amadio P, et al. Among authors: werba jp. Biomed Pharmacother. 2021 Apr;136:111259. doi: 10.1016/j.biopha.2021.111259. Epub 2021 Jan 12. Biomed Pharmacother. 2021. PMID: 33450492 Free article.

9

Drug control of reverse cholesterol transport.

Franceschini G, Werba JP, Calabresi L. Franceschini G, et al. Among authors: werba jp. Pharmacol Ther. 1994;61(3):289-324. doi: 10.1016/0163-7258(94)90014-0. Pharmacol Ther. 1994. PMID: 7938176 Review.

10

Tolerability of fibric acids. Comparative data and biochemical bases.

Sirtori CR, Calabresi L, Werba JP, Franceschini G. Sirtori CR, et al. Among authors: werba jp. Pharmacol Res. 1992 Oct-Nov;26(3):243-60. doi: 10.1016/1043-6618(92)90212-t. Pharmacol Res. 1992. PMID: 1437989 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results